Soren Acquisition (SORN) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $10.06, +0.30% vs the prior close of $10.03.
- Volume 207 shares, 0.0x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
SORN ends flat (+0.3%) to $10.06, a 6-month high. Closed at $10.06, +0.30% vs the prior close of $10.03. Day range $10.06–$10.06, opened at $10.06.
SORN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SORN ends flat (+0.3%) to $10.06, a 6-month high
- Closed at $10.06, +0.30% vs the prior close of $10.03. Day range $10.06–$10.06, opened at $10.06.
- Volume was 207 shares, 0.0x its 50-day average of 23.57K — lighter than usual.
- Price is +0.6% vs its 50-day average ($10.00).
- 52-week range $9.81–$10.88; today's close sits at 23% of that range, 7.5% below the 52-week high.
Oct 15, 2026 — SORN ends flat (+0.1%) to $10.03
- Closed at $10.03, +0.10% vs the prior close of $10.02. Day range $10.03–$10.04, opened at $10.04.
- Volume was 1.30K shares, 0.1x its 50-day average of 23.54K — lighter than usual.
- Price is +0.4% vs its 50-day average ($9.99).
- 52-week range $9.81–$10.88; today's close sits at 21% of that range, 7.8% below the 52-week high.
Oct 14, 2026 — SORN ends flat (+0.0%) to $10.02, 8 down days in a row
- Closed at $10.02, +0.00% vs the prior close of $10.02. Day range $10.02–$10.02, opened at $10.02.
- Price is +0.3% vs its 50-day average ($9.99).
- 52-week range $9.81–$10.88; today's close sits at 20% of that range, 7.9% below the 52-week high.
- That makes 8 straight losses.
Oct 13, 2026 — SORN ends flat (+0.0%) to $10.02, 7 down days in a row
- Closed at $10.02, +0.00% vs the prior close of $10.02. Day range $10.02–$10.02, opened at $10.02.
- Price is +0.3% vs its 50-day average ($9.99).
- 52-week range $9.81–$10.88; today's close sits at 20% of that range, 7.9% below the 52-week high.
- That makes 7 straight losses.
Oct 12, 2026 — SORN ends flat (+0.0%) to $10.02, 6 down days in a row
- Closed at $10.02, +0.00% vs the prior close of $10.02. Day range $10.02–$10.02, opened at $10.02.
- Price is +0.3% vs its 50-day average ($9.99).
- 52-week range $9.81–$10.88; today's close sits at 20% of that range, 7.9% below the 52-week high.
- That makes 6 straight losses.
Oct 9, 2026 — SORN ends flat (+0.0%) to $10.02, 5 down days in a row
- Closed at $10.02, +0.00% vs the prior close of $10.02. Day range $10.02–$10.02, opened at $10.02.
- Volume was 600 shares, 0.0x its 50-day average of 23.53K — lighter than usual.
- Price is +0.3% vs its 50-day average ($9.99).
- 52-week range $9.81–$10.88; today's close sits at 20% of that range, 7.9% below the 52-week high.
- That makes 5 straight losses.
Oct 8, 2026 — SORN ends flat (-0.2%) to $10.02, 4 down days in a row
- Closed at $10.02, -0.20% vs the prior close of $10.04. Day range $10.02–$10.02, opened at $10.02.
- Volume was 600 shares, 0.0x its 50-day average of 23.53K — lighter than usual.
- Price is +0.3% vs its 50-day average ($9.99).
- 52-week range $9.81–$10.88; today's close sits at 20% of that range, 7.9% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 — SORN ends flat (+0.0%) to $10.04, 3 down days in a row
- Closed at $10.04, +0.00% vs the prior close of $10.04. Day range $10.03–$10.04, opened at $10.04.
- Volume was 35.30K shares, 1.5x its 50-day average of 22.82K.
- Price is +0.5% vs its 50-day average ($9.99).
- 52-week range $9.81–$10.88; today's close sits at 21% of that range, 7.7% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — SORN ends flat (+0.0%) to $10.04
- Closed at $10.04, +0.00% vs the prior close of $10.04. Day range $10.04–$10.04, opened at $10.04.
- Price is +0.6% vs its 50-day average ($9.98).
- 52-week range $9.81–$10.88; today's close sits at 21% of that range, 7.7% below the 52-week high.
Oct 5, 2026 — SORN ends flat (+0.0%) to $10.04
- Closed at $10.04, +0.00% vs the prior close of $10.04. Day range $10.04–$10.04, opened at $10.04.
- Price is +0.6% vs its 50-day average ($9.98).
- 52-week range $9.81–$10.88; today's close sits at 21% of that range, 7.7% below the 52-week high.
Oct 2, 2026 — SORN ends flat (+0.2%) to $10.04, a 6-month high
- Closed at $10.04, +0.20% vs the prior close of $10.02. Day range $10.02–$10.04, opened at $10.04.
- Volume was 6.20K shares, 0.3x its 50-day average of 24.72K — lighter than usual.
- Price is +0.6% vs its 50-day average ($9.98).
- 52-week range $9.81–$10.88; today's close sits at 21% of that range, 7.7% below the 52-week high.
SORN latest news & SEC filings
Every SEC filing by or about SORN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: $2.03M
Things to know before you trade SORN
- How much it moves: over the last 20 sessions the average daily move was 0.05% (largest 0.3%). That is a relatively calm stock.
- Liquidity: about 15.54K shares (≈$156.34K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $10.06 vs a range of $9.81–$10.88 (23% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 10-Q Aug 13, 2026; 10-Q May 14, 2026; 10-K Mar 27, 2026.
- Listing: Nasdaq · industry: Blank Checks.
SORN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 10.06 | 10.06 | 10.06 | 10.06 | 207 |
| Oct 15, 2026 | 10.04 | 10.04 | 10.03 | 10.03 | 1.30K |
| Oct 14, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Oct 13, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Oct 12, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Oct 9, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 600 |
| Oct 8, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 600 |
| Oct 7, 2026 | 10.04 | 10.04 | 10.03 | 10.04 | 35.30K |
| Oct 6, 2026 | 10.04 | 10.04 | 10.04 | 10.04 | 0 |
| Oct 5, 2026 | 10.04 | 10.04 | 10.04 | 10.04 | 0 |
| Oct 2, 2026 | 10.04 | 10.04 | 10.02 | 10.04 | 6.20K |
| Oct 1, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Sep 30, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Sep 29, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Sep 28, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Sep 25, 2026 | 10.02 | 10.03 | 10.02 | 10.02 | 56.40K |
| Sep 24, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 126.60K |
| Sep 23, 2026 | 10.02 | 10.03 | 10.01 | 10.01 | 83.60K |
| Sep 22, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
| Sep 21, 2026 | 10.02 | 10.02 | 10.02 | 10.02 | 0 |
About Soren Acquisition
Soren Acquisition (SORN) is listed on the Nasdaq and classified by the SEC under “Blank Checks”. Its business address is in MIAMI, FL. State of incorporation: Cayman Islands. Fiscal year ends December 31. SEC CIK 2086263.
SORN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Rezze Arghavan Di | Chief Executive Officer | Jan 6, 2026 |
| Spencer Nathan Gerrol | Director | Jan 6, 2026 |
| Charles Newman Iii Kahn | Director | Jan 6, 2026 |
| Marc Mazur | Director | Jan 6, 2026 |
| Jamie B Weber | Chief Financial Officer | Jan 6, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Rezze Arghavan Di | Chief Executive Officer | Jan 6, 2026 |
| Jamie B Weber | Chief Financial Officer | Jan 6, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SORN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $259.29M, total liabilities $302.62K, cash $— (as of Jun 30, 2026).
SORN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Blank Checks
Southport Acquisition Corp. II (PORT-UN)Bold Eagle Acquisition (BEAG)Innventure (INV)Live Oak Acquisition Corp. VI (LOVIU)Pine Tree Acquisition (PAXGU)Frazier Life Sciences Acquisition Corp. II (FLSC)Archimedes Tech SPAC Partners II (ATII)Bluerock Acquisition Corp. II (BRRKU)EQV Ventures Acquisition Corp. II (EVAC)Pyrophyte Acquisition Corp. II (PAII)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SORN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.